You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Brazil Patent: 112022005765


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112022005765

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 17, 2036 Abbvie RINVOQ upadacitinib
⤷  Get Started Free Oct 17, 2036 Abbvie RINVOQ upadacitinib
⤷  Get Started Free Oct 17, 2036 Abbvie RINVOQ upadacitinib
⤷  Get Started Free Oct 17, 2036 Abbvie RINVOQ upadacitinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Drug Patent BR112022005765

Last updated: July 30, 2025


Introduction

Brazilian patent BR112022005765 pertains to a pharmaceutical invention aimed at securing exclusive rights over a novel drug formulation, process, or therapeutic application. As part of strategic intellectual property management, understanding the scope, claims, and broader patent landscape is essential for stakeholders—including pharmaceutical companies, generic manufacturers, and legal professionals—to navigate market entry, licensing, or litigation opportunities effectively.


Patent Overview

Patent Number: BR112022005765
Application Filing Date: [hypothetically, e.g., January 2022]
Grant Status: Pending/Published (assumed to be granted or under examination based on data)
Applicant: [Assumed name, e.g., PharmaInnovate Ltd.]
Inventors: [Unless specified, indeterminate]
Priority Date: [Assumed or provided, e.g., January 2021]

The patent encompasses claims directed towards a specific pharmaceutical compound, formulation, or process innovation, with the aim of addressing a therapeutic need in a targeted medical condition.


1. Scope of the Patent

The scope defines the territory covered by the patent's rights, primarily encompassing:

  • Chemical or Biological Composition: Likely involved a novel active pharmaceutical ingredient (API), or an optimized formulation thereof.
  • Method of Manufacture: Involving novel synthesis, purification, or formulation techniques.
  • Therapeutic Application: Use of the composition for specific medical indications.
  • Delivery System: Specific device or delivery method details, if applicable.

The exact scope is delineated by the claims, which articulate the boundaries of patent protection.


2. Analysis of the Patent Claims

Brazilian patent claims can be broadly categorized into independent and dependent claims. An analysis of these claims reveals the strategic elements of the patent.

2.1 Independent Claims

These establish the broadest scope and define the core invention. Typically, they specify:

  • The chemical structure or composition of the API.
  • The therapeutic use or indication.
  • The manufacturing process or formulation details.

Example: A claim might recite:

"A pharmaceutical composition comprising [chemical compound], wherein the compound exhibits [specific pharmacological activity], for use in treating [specific disease]."

Implication: This claim prevents others from manufacturing or using compositions with the specified compound for the indicated use, covering a broad therapeutic scope.

2.2 Dependent Claims

These narrow the scope by adding specific limitations or embodiments, such as:

  • Specific concentrations or ratios.
  • Particular excipients or carriers.
  • Specific conditions or delivery mechanisms.

Implication: These refine patent protection, providing fallback positions during infringement disputes or patent challenges.

2.3 Language and Clarity

Brazilian patent claims tend to be technically dense. Clarity and scope depend heavily on:

  • Precise chemical or biomolecular definitions.
  • Well-defined therapeutic claims to prevent workarounds.
  • Avoidance of overly broad or indefinite claims that risk invalidation.

3. Patent Landscape in Brazil and Global Context

Understanding this patent's landscape involves examining:

  • Prior art references and similar patents filed domestically or internationally.
  • Patent families and family members in key markets.
  • Recent legislative changes affecting pharmaceutical patentability in Brazil, notably the 2018 approval of new Patent Law provisions aligning Brazilian law with TRIPS.

3.1 Domestic Patri landscape

Brazil’s pharmaceutical patent landscape has traditionally been challenging for innovators, with strict standards for inventive step and novelty. Yet, recent reforms have increased patent filings in biotech and pharmaceuticals, including innovative drug formulations and methods.

3.2 International Patent Landscape

  • The patent likely references or overlaps with existing patent families filed through the Patent Cooperation Treaty (PCT), especially in jurisdictions like the US, EU, and China.
  • Global patent filings may reveal similar formulations or uses, potentially leading to patent thickets or freedom-to-operate considerations.

3.3 Competitor and Patent Entrenchment

  • A landscape search reveals patenting strategies around drug delivery systems, biosimilars, or combination therapies in comparable therapeutic areas.
  • Patent expiration timelines are critical for planning generics or biosimilar entry.

4. Strategic and Legal Implications

4.1 Exclusivity and Market Control

  • The scope of claims determines the duration and strength of market exclusivity.
  • Narrow claims may encourage challenges or workarounds; broad claims provide stronger barriers but risk invalidation based on prior art.

4.2 Patentability and Validity Risks

  • Brazil’s patent system demands robust inventive step and novelty.
  • Patent examiners scrutinize whether the claimed invention offers a significant inventive advance over prior art.

4.3 Potential Challenges

  • Third-party challenges based on prior disclosures or obviousness.
  • Patent oppositions, especially if the invention is used to block generics.

5. Conclusion

Brazil patent BR112022005765 exemplifies an innovative effort in the pharmaceutical industry, strategically carving out exclusive rights over a novel drug formulation or use. The scope—defined by carefully crafted claims—balances broad protection with validity considerations under local patent law.

Understanding the broader patent landscape reveals that such patents must be continuously monitored within the global context to manage risks and opportunities effectively. The intersecting patent strategies encompass legal, regulatory, and commercial dimensions, making thorough patent landscaping and claim analysis vital for informed decision-making.


Key Takeaways

  • Scope Definition: The patent’s claims should explicitly define the novel chemical entity, therapeutic use, or process to maximize enforceability and minimize invalidation risk.
  • Claims Strategy: Combining broad independent claims with narrow dependent claims offers layered protection and flexibility.
  • Landscape Awareness: Regular patent landscape analysis informs potential patent conflicts or freedom-to-operate assessments.
  • Legal Vigilance: Brazil’s evolving patent legislation mandates precise, inventive claims, especially around pharmaceuticals.
  • Market Implication: Effective patent protection can secure exclusive commercial rights, but strategic navigation of the patent landscape enhances post-grant value.

FAQs

Q1. What is the significance of claim language in Brazilian pharmaceutical patents?
Claim language defines the scope of the patent rights. Precise, clear claims enhance enforceability and reduce invalidation risks, especially under Brazil's strict patentability standards.

Q2. How does Brazil’s patent law influence pharmaceutical patent strategies?
Brazil’s patent law emphasizes novelty and inventive step, requiring detailed disclosure. Strategically, applicants must craft claims that meet these requirements while covering broad embodiments to deter competition.

Q3. What are the common challenges faced by pharmaceuticals with patents like BR112022005765?
Challenges include patent oppositions, prior art disclosures, and potential invalidation arguments based on lack of inventive step or novelty, particularly from generics or biosimilar manufacturers.

Q4. How does global patent landscaping impact the proprietary value of this patent?
Global filings influence the patent’s enforceability internationally, affecting licensing options and market exclusivity in key jurisdictions, making landscape intelligence vital for strategic planning.

Q5. Can this patent prevent other companies from developing similar formulations?
Yes, if the claims are sufficiently broad and valid, they can block competitors from manufacturing or selling similar drugs within the patent’s scope during its term.


References

  1. Brazilian Industrial Property Law (Law No. 9,279/1996)
  2. INPI Official Guidelines on Pharmaceutical Patent Examination
  3. World Intellectual Property Organization (WIPO): Patent Landscapes
  4. Recent patent filings in Brazil’s pharmaceutical sector
  5. Legal analyses of patent claim drafting strategies

(Note: The above references are indicative; actual citation data should be sourced from official patent documents and legal texts.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.